| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Multidetector Computed Tomography | 3 | 2019 | 307 | 1.25 | Why? |
| Heart Valves | 2 | 2019 | 52 | 0.92 | Why? |
| Solar Energy | 2 | 2018 | 9 | 0.89 | Why? |
| Myocardium | 4 | 2021 | 2323 | 0.86 | Why? |
| Central Serous Chorioretinopathy | 1 | 2020 | 20 | 0.86 | Why? |
| Giant Cell Tumor of Tendon Sheath | 1 | 2019 | 3 | 0.81 | Why? |
| Finger Phalanges | 1 | 2019 | 7 | 0.80 | Why? |
| Paclitaxel | 2 | 2017 | 124 | 0.80 | Why? |
| Fractures, Malunited | 1 | 2018 | 2 | 0.79 | Why? |
| Finger Joint | 1 | 2019 | 18 | 0.79 | Why? |
| Scaphoid Bone | 1 | 2018 | 5 | 0.79 | Why? |
| Amphetamines | 1 | 2018 | 7 | 0.78 | Why? |
| Designer Drugs | 1 | 2018 | 12 | 0.78 | Why? |
| Spironolactone | 1 | 2020 | 114 | 0.77 | Why? |
| Forensic Toxicology | 1 | 2018 | 27 | 0.77 | Why? |
| Carcinoma, Small Cell | 1 | 2018 | 16 | 0.76 | Why? |
| Osteolysis | 1 | 2019 | 57 | 0.76 | Why? |
| Achromobacter denitrificans | 1 | 2018 | 2 | 0.76 | Why? |
| Amphetamine-Related Disorders | 1 | 2018 | 31 | 0.75 | Why? |
| Calcium Compounds | 2 | 2018 | 13 | 0.75 | Why? |
| Retinal Vasculitis | 1 | 2018 | 33 | 0.74 | Why? |
| Vitreous Hemorrhage | 1 | 2017 | 4 | 0.74 | Why? |
| Retinal Necrosis Syndrome, Acute | 1 | 2017 | 13 | 0.72 | Why? |
| Heart Valve Prosthesis | 3 | 2019 | 533 | 0.72 | Why? |
| Prosthesis Failure | 2 | 2019 | 195 | 0.71 | Why? |
| Echocardiography, Transesophageal | 2 | 2019 | 447 | 0.71 | Why? |
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 25 | 0.70 | Why? |
| Food Additives | 1 | 2017 | 27 | 0.70 | Why? |
| Retinal Artery Occlusion | 1 | 2018 | 57 | 0.70 | Why? |
| Electric Power Supplies | 1 | 2017 | 30 | 0.69 | Why? |
| Echocardiography, Three-Dimensional | 1 | 2019 | 135 | 0.69 | Why? |
| Nickel | 1 | 2017 | 55 | 0.67 | Why? |
| Eye Infections, Bacterial | 1 | 2018 | 86 | 0.66 | Why? |
| Oxides | 1 | 2017 | 77 | 0.65 | Why? |
| Postoperative Hemorrhage | 1 | 2018 | 183 | 0.64 | Why? |
| Substance Abuse Detection | 1 | 2018 | 192 | 0.64 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2021 | 669 | 0.64 | Why? |
| Endophthalmitis | 1 | 2018 | 105 | 0.64 | Why? |
| Deoxycytidine | 1 | 2017 | 116 | 0.63 | Why? |
| Biliary Tract Neoplasms | 1 | 2017 | 93 | 0.61 | Why? |
| Aortic Valve Insufficiency | 1 | 2017 | 136 | 0.60 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.59 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2019 | 552 | 0.59 | Why? |
| Titanium | 1 | 2017 | 175 | 0.58 | Why? |
| Photochemotherapy | 1 | 2020 | 297 | 0.57 | Why? |
| Visual Acuity | 2 | 2020 | 790 | 0.55 | Why? |
| Eating | 1 | 2017 | 395 | 0.54 | Why? |
| Psychotropic Drugs | 1 | 2018 | 396 | 0.52 | Why? |
| Naphthalenes | 3 | 2018 | 94 | 0.51 | Why? |
| Calcium | 1 | 2018 | 708 | 0.51 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.49 | Why? |
| Fractures, Bone | 1 | 2018 | 487 | 0.48 | Why? |
| Glycopeptides | 3 | 2019 | 199 | 0.46 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.45 | Why? |
| Heart | 1 | 2021 | 1791 | 0.45 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.44 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.41 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.40 | Why? |
| Lung Neoplasms | 4 | 2018 | 3228 | 0.38 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.38 | Why? |
| Aortic Valve Stenosis | 1 | 2017 | 741 | 0.38 | Why? |
| Metabolic Engineering | 2 | 2018 | 41 | 0.37 | Why? |
| Fundus Oculi | 2 | 2020 | 237 | 0.37 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.37 | Why? |
| Myocarditis | 2 | 2021 | 2731 | 0.36 | Why? |
| Microsomes, Liver | 2 | 2018 | 96 | 0.35 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.35 | Why? |
| Intravitreal Injections | 3 | 2018 | 347 | 0.35 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2021 | 869 | 0.33 | Why? |
| Proteomics | 4 | 2019 | 2481 | 0.32 | Why? |
| Coronary Artery Disease | 2 | 2018 | 2570 | 0.32 | Why? |
| Cytochrome P-450 Enzyme System | 2 | 2018 | 144 | 0.32 | Why? |
| Tandem Mass Spectrometry | 4 | 2019 | 1031 | 0.31 | Why? |
| Fluorescein Angiography | 2 | 2020 | 426 | 0.30 | Why? |
| Tomography, X-Ray Computed | 10 | 2021 | 25144 | 0.29 | Why? |
| Chromatography, Liquid | 5 | 2019 | 640 | 0.29 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.28 | Why? |
| Diet | 1 | 2017 | 2052 | 0.27 | Why? |
| Depression | 3 | 2017 | 14116 | 0.27 | Why? |
| Immunoprecipitation | 3 | 2019 | 300 | 0.26 | Why? |
| Republic of Korea | 7 | 2021 | 5858 | 0.26 | Why? |
| Predictive Value of Tests | 7 | 2021 | 9537 | 0.26 | Why? |
| Rats, Sprague-Dawley | 4 | 2019 | 987 | 0.23 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.23 | Why? |
| Chromosomes, Human | 2 | 2019 | 38 | 0.23 | Why? |
| alpha-Fetoproteins | 2 | 2019 | 72 | 0.23 | Why? |
| Radiography, Dual-Energy Scanned Projection | 2 | 2018 | 53 | 0.22 | Why? |
| Adenocarcinoma | 2 | 2018 | 651 | 0.22 | Why? |
| Anxiety | 2 | 2017 | 17311 | 0.22 | Why? |
| Reproducibility of Results | 6 | 2019 | 11304 | 0.21 | Why? |
| Transcriptome | 3 | 2018 | 3466 | 0.21 | Why? |
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2019 | 7 | 0.20 | Why? |
| Tomography, Optical Coherence | 2 | 2017 | 1008 | 0.20 | Why? |
| Curettage | 1 | 2019 | 8 | 0.20 | Why? |
| Chromatography, Reverse-Phase | 1 | 2019 | 9 | 0.20 | Why? |
| Carpal Bones | 1 | 2018 | 1 | 0.20 | Why? |
| Photoacoustic Techniques | 1 | 2019 | 31 | 0.20 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.20 | Why? |
| Saccharomyces cerevisiae | 2 | 2018 | 339 | 0.20 | Why? |
| Preimplantation Diagnosis | 1 | 2019 | 16 | 0.20 | Why? |
| Tomography, Optical | 1 | 2018 | 4 | 0.20 | Why? |
| Male | 38 | 2021 | 367725 | 0.20 | Why? |
| Arthrodesis | 1 | 2018 | 9 | 0.20 | Why? |
| Peptide Elongation Factor 1 | 1 | 2019 | 38 | 0.19 | Why? |
| Bone Screws | 1 | 2018 | 30 | 0.19 | Why? |
| Ornithine Decarboxylase | 1 | 2018 | 1 | 0.19 | Why? |
| Neuregulin-1 | 1 | 2018 | 8 | 0.19 | Why? |
| Ornithine | 1 | 2018 | 5 | 0.19 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.19 | Why? |
| Mannosephosphates | 1 | 2018 | 7 | 0.19 | Why? |
| Magnesium Oxide | 1 | 2018 | 3 | 0.19 | Why? |
| Karnofsky Performance Status | 1 | 2018 | 88 | 0.19 | Why? |
| Bone Transplantation | 1 | 2018 | 38 | 0.19 | Why? |
| Microorganisms, Genetically-Modified | 1 | 2018 | 19 | 0.19 | Why? |
| Prosthesis Design | 2 | 2019 | 594 | 0.19 | Why? |
| Lens Capsule, Crystalline | 1 | 2018 | 6 | 0.19 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.19 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2018 | 27 | 0.19 | Why? |
| Imides | 1 | 2018 | 10 | 0.19 | Why? |
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2018 | 22 | 0.19 | Why? |
| Postmortem Changes | 1 | 2019 | 133 | 0.19 | Why? |
| Indoles | 2 | 2018 | 1243 | 0.19 | Why? |
| Arthroscopy | 1 | 2018 | 46 | 0.19 | Why? |
| Gravity, Altered | 1 | 2017 | 1 | 0.19 | Why? |
| Response Evaluation Criteria in Solid Tumors | 1 | 2018 | 37 | 0.19 | Why? |
| Wrist Joint | 1 | 2018 | 34 | 0.19 | Why? |
| Glucuronosyltransferase | 1 | 2018 | 24 | 0.18 | Why? |
| Semiconductors | 1 | 2018 | 25 | 0.18 | Why? |
| Middle Aged | 29 | 2021 | 270681 | 0.18 | Why? |
| Cannabinoid Receptor Agonists | 1 | 2018 | 24 | 0.18 | Why? |
| Oncogene Proteins, Fusion | 1 | 2018 | 52 | 0.18 | Why? |
| Acceleration | 1 | 2017 | 26 | 0.18 | Why? |
| Construction Materials | 1 | 2018 | 57 | 0.18 | Why? |
| Blastocyst | 1 | 2019 | 65 | 0.18 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 203 | 0.18 | Why? |
| Carcinoma, Hepatocellular | 2 | 2019 | 1222 | 0.18 | Why? |
| Anterior Chamber | 1 | 2018 | 26 | 0.18 | Why? |
| Magnetic Resonance Imaging | 3 | 2021 | 6551 | 0.18 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 187 | 0.18 | Why? |
| Corticosterone | 1 | 2017 | 18 | 0.18 | Why? |
| Flavin-Adenine Dinucleotide | 1 | 2017 | 6 | 0.18 | Why? |
| Nucleus Accumbens | 1 | 2017 | 16 | 0.18 | Why? |
| Endolymphatic Sac | 1 | 2017 | 2 | 0.18 | Why? |
| Receptors, Adrenergic, beta-1 | 1 | 2017 | 4 | 0.18 | Why? |
| Brain Chemistry | 1 | 2017 | 49 | 0.17 | Why? |
| Electrochemistry | 1 | 2017 | 26 | 0.17 | Why? |
| Evoked Potentials, Auditory, Brain Stem | 1 | 2017 | 42 | 0.17 | Why? |
| Maze Learning | 1 | 2017 | 35 | 0.17 | Why? |
| Lysine | 1 | 2018 | 153 | 0.17 | Why? |
| Physical Conditioning, Animal | 1 | 2017 | 31 | 0.17 | Why? |
| Photosensitizing Agents | 1 | 2020 | 279 | 0.17 | Why? |
| Fish Oils | 1 | 2017 | 33 | 0.17 | Why? |
| Quetiapine Fumarate | 1 | 2017 | 30 | 0.17 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.17 | Why? |
| Retinal Hemorrhage | 1 | 2017 | 50 | 0.17 | Why? |
| Histone Demethylases | 1 | 2017 | 31 | 0.17 | Why? |
| Citalopram | 1 | 2017 | 44 | 0.17 | Why? |
| Retinal Ganglion Cells | 1 | 2017 | 80 | 0.17 | Why? |
| Vacuolar Proton-Translocating ATPases | 1 | 2016 | 30 | 0.17 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 32 | 0.17 | Why? |
| Hearing Tests | 1 | 2017 | 76 | 0.17 | Why? |
| Reperfusion Injury | 1 | 2019 | 178 | 0.17 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2018 | 239 | 0.17 | Why? |
| Neoplasms, Experimental | 1 | 2017 | 67 | 0.16 | Why? |
| Antidepressive Agents, Second-Generation | 1 | 2017 | 41 | 0.16 | Why? |
| Vitreous Body | 1 | 2018 | 161 | 0.16 | Why? |
| Fracture Fixation, Internal | 1 | 2018 | 188 | 0.16 | Why? |
| Phacoemulsification | 1 | 2018 | 102 | 0.16 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.16 | Why? |
| Collagen Type IV | 1 | 2016 | 12 | 0.16 | Why? |
| Laminin | 1 | 2016 | 23 | 0.16 | Why? |
| Drug Contamination | 1 | 2017 | 104 | 0.16 | Why? |
| Choroid | 1 | 2017 | 112 | 0.16 | Why? |
| Basement Membrane | 1 | 2016 | 30 | 0.16 | Why? |
| Liver Neoplasms | 2 | 2019 | 1666 | 0.16 | Why? |
| Behavior, Animal | 1 | 2017 | 136 | 0.16 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 133 | 0.16 | Why? |
| Bevacizumab | 1 | 2017 | 149 | 0.16 | Why? |
| Polysomnography | 1 | 2018 | 296 | 0.16 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.16 | Why? |
| Rifampin | 1 | 2018 | 276 | 0.15 | Why? |
| Humans | 52 | 2021 | 930598 | 0.15 | Why? |
| Cannabinoids | 1 | 2018 | 134 | 0.15 | Why? |
| Salvage Therapy | 1 | 2018 | 417 | 0.15 | Why? |
| Reoperation | 1 | 2018 | 544 | 0.15 | Why? |
| Radiation Dosage | 2 | 2018 | 585 | 0.15 | Why? |
| Cytoplasm | 1 | 2017 | 304 | 0.15 | Why? |
| Macular Edema | 1 | 2017 | 139 | 0.15 | Why? |
| Microscopy | 1 | 2019 | 414 | 0.15 | Why? |
| Ubiquitination | 1 | 2017 | 343 | 0.15 | Why? |
| Movement | 1 | 2017 | 232 | 0.15 | Why? |
| Female | 33 | 2021 | 380317 | 0.15 | Why? |
| Particulate Matter | 2 | 2018 | 3249 | 0.15 | Why? |
| Administration, Oral | 2 | 2020 | 2340 | 0.15 | Why? |
| Radiation Exposure | 1 | 2017 | 161 | 0.15 | Why? |
| Olfactory Mucosa | 1 | 2018 | 372 | 0.15 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.15 | Why? |
| Hearing Loss, Sudden | 1 | 2017 | 103 | 0.15 | Why? |
| Genetic Testing | 1 | 2019 | 395 | 0.15 | Why? |
| Fertilization in Vitro | 1 | 2019 | 330 | 0.15 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 286 | 0.15 | Why? |
| Vehicle Emissions | 1 | 2017 | 328 | 0.14 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2017 | 149 | 0.14 | Why? |
| Retrospective Studies | 16 | 2021 | 105322 | 0.14 | Why? |
| Disease-Free Survival | 2 | 2017 | 1654 | 0.14 | Why? |
| Lysosomes | 1 | 2018 | 416 | 0.14 | Why? |
| Aged | 23 | 2021 | 215776 | 0.14 | Why? |
| Hearing Loss, Sensorineural | 1 | 2017 | 159 | 0.14 | Why? |
| Epithelium | 1 | 2017 | 330 | 0.14 | Why? |
| Combined Modality Therapy | 3 | 2018 | 3395 | 0.14 | Why? |
| Febrile Neutropenia | 1 | 2017 | 179 | 0.14 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.14 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.14 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.14 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 291 | 0.14 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.14 | Why? |
| Glycoproteins | 1 | 2019 | 615 | 0.13 | Why? |
| Neonatal Screening | 1 | 2017 | 285 | 0.13 | Why? |
| Feasibility Studies | 3 | 2019 | 3467 | 0.13 | Why? |
| Neuroprotective Agents | 1 | 2016 | 240 | 0.13 | Why? |
| Glycosylation | 4 | 2019 | 1255 | 0.13 | Why? |
| Mitral Valve | 1 | 2017 | 342 | 0.13 | Why? |
| Limit of Detection | 2 | 2019 | 2698 | 0.13 | Why? |
| Tacrolimus | 1 | 2016 | 435 | 0.13 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.13 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.13 | Why? |
| Hearing Loss | 1 | 2017 | 225 | 0.13 | Why? |
| Polymers | 1 | 2018 | 507 | 0.13 | Why? |
| Databases, Protein | 1 | 2017 | 523 | 0.13 | Why? |
| Mitral Valve Insufficiency | 1 | 2017 | 302 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.13 | Why? |
| Biomarkers, Tumor | 2 | 2019 | 1314 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Rats | 2 | 2017 | 2764 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Colon | 1 | 2017 | 669 | 0.11 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.11 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.11 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 398 | 0.11 | Why? |
| Radiography, Thoracic | 4 | 2021 | 5486 | 0.11 | Why? |
| Water Pollutants, Chemical | 1 | 2017 | 410 | 0.11 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.11 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.11 | Why? |
| Radiography | 1 | 2019 | 1576 | 0.11 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Neurons | 1 | 2016 | 864 | 0.10 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.10 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.10 | Why? |
| Gene Expression Regulation | 3 | 2017 | 4020 | 0.10 | Why? |
| Fucose | 2 | 2019 | 38 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Autophagy | 1 | 2016 | 960 | 0.10 | Why? |
| Lung | 5 | 2021 | 31049 | 0.09 | Why? |
| Myocardial Ischemia | 1 | 2016 | 781 | 0.09 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.09 | Why? |
| Pain | 1 | 2017 | 1084 | 0.09 | Why? |
| Dietary Supplements | 2 | 2018 | 2251 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Alternative Splicing | 2 | 2018 | 82 | 0.09 | Why? |
| Antipsychotic Agents | 1 | 2017 | 887 | 0.09 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.09 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Mass Spectrometry | 3 | 2019 | 1165 | 0.09 | Why? |
| X-Ray Diffraction | 2 | 2018 | 249 | 0.09 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.09 | Why? |
| Coronary Angiography | 1 | 2017 | 2275 | 0.08 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.08 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.08 | Why? |
| Adult | 17 | 2020 | 244371 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Membrane Glycoproteins | 1 | 2016 | 2273 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1692 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.07 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.07 | Why? |
| Air Pollutants | 2 | 2018 | 3110 | 0.06 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Amino Acid Sequence | 3 | 2019 | 6049 | 0.06 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.06 | Why? |
| Animals | 7 | 2020 | 78931 | 0.05 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.05 | Why? |
| Neoplasm Staging | 2 | 2018 | 1999 | 0.05 | Why? |
| Vitronectin | 1 | 2019 | 2 | 0.05 | Why? |
| alpha 1-Antichymotrypsin | 1 | 2019 | 3 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.05 | Why? |
| Isomerism | 1 | 2019 | 13 | 0.05 | Why? |
| Carbohydrate Conformation | 1 | 2019 | 46 | 0.05 | Why? |
| C-Reactive Protein | 3 | 2020 | 7972 | 0.05 | Why? |
| Cadaverine | 1 | 2018 | 2 | 0.05 | Why? |
| Receptor, ErbB-3 | 1 | 2018 | 7 | 0.05 | Why? |
| Putrescine | 1 | 2018 | 6 | 0.05 | Why? |
| Magnesium Hydroxide | 1 | 2018 | 1 | 0.05 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| Thermogravimetry | 1 | 2018 | 14 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Compressive Strength | 1 | 2018 | 16 | 0.05 | Why? |
| HL-60 Cells | 1 | 2018 | 60 | 0.05 | Why? |
| Silicates | 1 | 2018 | 19 | 0.05 | Why? |
| alpha-Glucosidases | 1 | 2018 | 39 | 0.05 | Why? |
| Carbonates | 1 | 2018 | 19 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2019 | 242 | 0.05 | Why? |
| Embryo, Mammalian | 1 | 2019 | 86 | 0.05 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.05 | Why? |
| Embryo Transfer | 1 | 2019 | 91 | 0.05 | Why? |
| Fullerenes | 1 | 2018 | 30 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2018 | 3608 | 0.05 | Why? |
| Coal | 1 | 2017 | 26 | 0.05 | Why? |
| Pregnancy Rate | 1 | 2019 | 134 | 0.05 | Why? |
| Antibiotics, Antitubercular | 1 | 2018 | 65 | 0.05 | Why? |
| Azoxymethane | 1 | 2017 | 6 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.05 | Why? |
| Electrons | 1 | 2018 | 53 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2018 | 199 | 0.04 | Why? |
| Perylene | 1 | 2018 | 34 | 0.04 | Why? |
| Calibration | 1 | 2019 | 307 | 0.04 | Why? |
| Injection, Intratympanic | 1 | 2017 | 16 | 0.04 | Why? |
| Forensic Pathology | 1 | 2019 | 109 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2018 | 126 | 0.04 | Why? |
| Polychlorinated Biphenyls | 1 | 2017 | 14 | 0.04 | Why? |
| Jurkat Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Immunosuppressive Agents | 1 | 2016 | 6331 | 0.04 | Why? |
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2017 | 2 | 0.04 | Why? |
| Biomass | 1 | 2017 | 80 | 0.04 | Why? |
| Acid Sensing Ion Channels | 1 | 2017 | 2 | 0.04 | Why? |
| Barium | 1 | 2017 | 10 | 0.04 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Isoproterenol | 1 | 2017 | 31 | 0.04 | Why? |
| Acridine Orange | 1 | 2016 | 1 | 0.04 | Why? |
| Lactobacillus | 1 | 2018 | 92 | 0.04 | Why? |
| Maternal Age | 1 | 2019 | 244 | 0.04 | Why? |
| Sequestosome-1 Protein | 1 | 2016 | 8 | 0.04 | Why? |
| Audiometry, Pure-Tone | 1 | 2017 | 64 | 0.04 | Why? |
| Atmosphere | 1 | 2018 | 103 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Adrenergic beta-2 Receptor Antagonists | 1 | 2017 | 16 | 0.04 | Why? |
| Mice, Inbred C3H | 1 | 2017 | 102 | 0.04 | Why? |
| Meniere Disease | 1 | 2017 | 14 | 0.04 | Why? |
| Nerve Fibers | 1 | 2017 | 73 | 0.04 | Why? |
| Microscopy, Electron, Scanning | 1 | 2018 | 221 | 0.04 | Why? |
| Adrenergic beta-1 Receptor Antagonists | 1 | 2017 | 47 | 0.04 | Why? |
| Seoul | 1 | 2017 | 206 | 0.04 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 54 | 0.04 | Why? |
| N-Acetylneuraminic Acid | 1 | 2019 | 198 | 0.04 | Why? |
| Catalase | 1 | 2017 | 97 | 0.04 | Why? |
| Reverse Transcription | 1 | 2020 | 673 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2018 | 391 | 0.04 | Why? |
| Fishes | 1 | 2017 | 99 | 0.04 | Why? |
| Wind | 1 | 2017 | 144 | 0.04 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 159 | 0.04 | Why? |
| Microarray Analysis | 1 | 2018 | 262 | 0.04 | Why? |
| Superoxide Dismutase | 1 | 2017 | 155 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2017 | 291 | 0.04 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.04 | Why? |
| Cell Hypoxia | 1 | 2017 | 141 | 0.04 | Why? |
| Iodine | 1 | 2018 | 116 | 0.04 | Why? |
| Pesticides | 1 | 2017 | 100 | 0.04 | Why? |
| Neuroglia | 1 | 2016 | 130 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.04 | Why? |
| Substrate Specificity | 1 | 2018 | 639 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 347 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.04 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.04 | Why? |
| Models, Animal | 1 | 2019 | 788 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Multimodal Imaging | 1 | 2020 | 534 | 0.04 | Why? |
| Artifacts | 1 | 2017 | 250 | 0.04 | Why? |
| Retinal Vein Occlusion | 1 | 2017 | 129 | 0.04 | Why? |
| Microtubule-Associated Proteins | 1 | 2016 | 187 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.04 | Why? |
| Genome | 1 | 2018 | 341 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.04 | Why? |
| Protein Transport | 1 | 2016 | 487 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Reference Standards | 1 | 2019 | 1163 | 0.04 | Why? |
| Metabolic Networks and Pathways | 1 | 2016 | 285 | 0.04 | Why? |
| Spermatozoa | 1 | 2017 | 244 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
| DNA, Complementary | 1 | 2016 | 568 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Heart Failure | 1 | 2016 | 6638 | 0.03 | Why? |
| Primary Cell Culture | 1 | 2016 | 501 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.03 | Why? |
| Follow-Up Studies | 3 | 2017 | 17020 | 0.03 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.03 | Why? |
| Thermodynamics | 1 | 2018 | 873 | 0.03 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Diabetic Retinopathy | 1 | 2017 | 347 | 0.03 | Why? |
| Pregnancy | 3 | 2020 | 23879 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Testis | 1 | 2017 | 566 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Hot Temperature | 1 | 2019 | 1299 | 0.03 | Why? |
| Cell Survival | 1 | 2016 | 1581 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Image Processing, Computer-Assisted | 1 | 2019 | 1383 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.02 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Myocytes, Cardiac | 1 | 2016 | 804 | 0.02 | Why? |
| Case-Control Studies | 2 | 2019 | 17671 | 0.02 | Why? |
| Cerebrovascular Disorders | 1 | 2017 | 1040 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Up-Regulation | 1 | 2016 | 2249 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Emotions | 1 | 2017 | 2418 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| State Medicine | 1 | 2017 | 2847 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Aerosols | 1 | 2017 | 5393 | 0.01 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.01 | Why? |
| Protein Binding | 1 | 2016 | 11430 | 0.01 | Why? |
| Mice | 1 | 2019 | 21357 | 0.01 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |